Sort   by:  
 Page size 
UnknownValidation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.
Not available
S-EPMC3438234 | biostudies-literature
UnknownSomatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.
Not available
S-EPMC4207878 | biostudies-literature
TranscriptomicsmicroRNA-1 negatively regulates expression of the hypertrophy-associated genes calmodulin and Mef2a
Calcium signaling is a central regulator of cardiomyocyte growth and function. Calmodulin is a critical mediator of calcium signals. Because the amount of calmodulin within cardiomyocytes is limiting, precise regulation of calmodulin expression may be an important for regulation of calcium signaling...
ORGANISM(S): Mus musculus 
2010-06-25 | E-GEOD-13874 | biostudies-arrayexpress
Genomicsena-DATASET-IJC-07-11-2014-17:58:39:549-794 - samples
Cancer exome reads consisting of FASTQ paired end reads from bone marrow samples
EGAD00001001058 | EGA
GenomicsMDS Sequencing Project Cancer Cell
Myelodysplastic syndromes (MDS) are uncommon entities, heterogeneous clinically and cytogenetically. The aim of the present study is to determine genetic alteration in this subset of patients. Expected results: Identification of new aberrations and genetic markers in order to detect novel genes invo...
EGAS00001001011 | EGA
GenomicsIJC Myelodysplastic Syndromes Sequencing Group
Data Access Committee EGAC00001000257
EGAC00001000257 | EGA
Sort   by:  
 Page size